Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartphone nudges and peer support: a new digital lifeline for opioid recovery?

NCT ID NCT07778394

Disease control Sponsor: Rhode Island Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 27, 2026 · Updated 2 times

Summary

This study tests whether a smartphone app called the Vira Platform, combined with peer recovery support, can help people with opioid use disorder stay on their medication (buprenorphine or methadone) and remain engaged in treatment. The app uses mobile sensing to detect patterns related to mood, sleep, and pleasure, and sends timely prompts to encourage positive activities. The trial will measure treatment retention and opioid use among participants.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Vira Platform: a smartphone app that uses mobile sensing to provide just-in-time nudges for behavioral activation, paired with peer recovery support.
What this could lead to
If effective, this digital platform could offer a scalable way to improve retention in medication-based treatment for opioid use disorder, potentially reducing overdose risk.
What could go wrong
This is a small early-stage trial, so results may not be generalizable. The app's success depends on user engagement and peer support quality, and it may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 22+ * Current Opioid Use Disorder diagnosis * Prescribed buprenorphine or methadone * Initiated or reinitiated buprenorphine or methadone treatment recently * Access to personal smartphone Exclusion Criteria: * Not fluent in English * Limited mental capacity or inability to provided informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mhealth are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mhealth Opioid-use disorder Peer support

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Rhode Island Hospital

    RECRUITING

    Providence, Rhode Island, 02903, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.